CloudLIMS

  Ensuring compliance with the EPA’s National Lead Laboratory Accreditation Program (NLLAP) is essential for laboratories conducting lead analysis in paint, dust, and soil. The EPA has released “Laboratory Quality Standards for Recognition (LQSR 4.0)” under the NLLAP, replacing LQSR 3.0 from 2007. Effective October 23, 2024, labs and accreditation bodies can follow either LQSR 3.0 or 4.0 until December 22, 2025. After that, compliance with LQSR 4.0 is mandatory for NLLAP recognition. Is your lab prepared for the new accreditation requirements? Our latest blog, “EPA’s NLLAP Decoded: Achieve Compliance with Advanced Environmental Laboratory Software,” explores: ✓ The significance of NLLAP accreditation ✓ Key revisions in the 2024 NLLAP update ✓ Steps involved in NLLAP accreditation ✓ How laboratories can get ahead of NLLAP accreditation ✓ How a LIMS can help with NLLAP compliance Read the Blog

Managing Certificates of Analysis (CoAs) manually can be time-consuming, error-prone, and a compliance risk. But what if you could automate the entire process, ensuring accuracy, efficiency, and full regulatory compliance? A robust LIMS can revolutionize how your lab manages CoAs, making it easier to generate, track, and verify these critical documents. In our latest blog, we break down: Key components of a CoA — What makes a CoA reliable and comprehensive Why CoA management matters — The role of CoAs in product integrity & compliance How LIMS enhances CoA management — Reduces manual errors through automation, ensures traceability, and enhances data integrity and security Essential LIMS features for effective CoA management and automation — What to look for in a robust system Read the Blog

  Cancer treatment has come a long way, yet relapse remains a major challenge—often leading to more aggressive disease. One key reason? Tumor heterogeneity . Differences within and between tumors can drive drug resistance, making standard treatments less effective. In our latest blog, we explore: Causes of tumor heterogeneity How tumor heterogeneity causes drug resistance and treatment failure Latest technologies for unraveling tumor heterogeneity How a LIMS enables labs to advance cancer research and improve patient outcomes Read the Blog